Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INS316 for Lung Cancer Diagnosis
NCT00008255Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Aug 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of uridine triphosphate in lung cancer, sponsored by Memorial Sloan Kettering Cancer Center. Started Aug 2000; status: completed.
02
Drugs
uridine triphosphate
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT00008255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00008255.